カテゴリー： QYResearch, 世界, 医療/バイオ

経口溶解フィルム製剤のグローバル市場2023年：口腔分散性フィルム、口腔粘膜フィルム

◆英語タイトル：Global Orally Dissolving Film Drug Market Research Report 2023
	◆商品コード：QYR23MA8838 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2023年3月 ◆ページ数：115 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD2,900 ⇒換算￥440,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD4,350 ⇒換算￥661,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD5,800 ⇒換算￥881,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の経口溶解フィルム製剤市場について調査・分析し、世界の経口溶解フィルム製剤市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（口腔分散性フィルム、口腔粘膜フィルム）、用途別セグメント分析（病院、ドラッグストア、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GSK、LTS、J&J、Indivior、Pfizer、Sanofi、Church & Dwight、tesa Labtec、Tapemark、Prestige、Sun Pharma、MonoSol、BioDelivery、Arx、ZIM、NAL Pharma、AdhexPharma、Aavishkar、IntelGenx Corp、APRなどが含まれています。世界の経口溶解フィルム製剤市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、経口溶解フィルム製剤市場規模を推定する際に考慮しました。

・経口溶解フィルム製剤市場の概要
- 製品の定義
- 経口溶解フィルム製剤のタイプ別セグメント
- 世界の経口溶解フィルム製剤市場規模：タイプ別分析（口腔分散性フィルム、口腔粘膜フィルム）
- 経口溶解フィルム製剤の用途別セグメント
- 世界の経口溶解フィルム製剤市場規模：用途別分析（病院、ドラッグストア、その他）
- 世界の経口溶解フィルム製剤市場規模予測（2018年-2029年）
- 経口溶解フィルム製剤の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 経口溶解フィルム製剤市場の競争状況およびトレンド

・経口溶解フィルム製剤の地域別市場規模
- 北米の経口溶解フィルム製剤市場規模（2018年-2029年）
- アメリカの経口溶解フィルム製剤市場規模（2018年-2029年）
- ヨーロッパの経口溶解フィルム製剤市場規模（2018年-2029年）
- アジア太平洋の経口溶解フィルム製剤市場規模（2018年-2029年）
- 中国の経口溶解フィルム製剤市場規模（2018年-2029年）
- 日本の経口溶解フィルム製剤市場規模（2018年-2029年）
- 韓国の経口溶解フィルム製剤市場規模（2018年-2029年）
- インドの経口溶解フィルム製剤市場規模（2018年-2029年）
- オーストラリアの経口溶解フィルム製剤市場規模（2018年-2029年）
- 中南米の経口溶解フィルム製剤市場規模（2018年-2029年）
- 中東・アフリカの経口溶解フィルム製剤市場規模（2018年-2029年）

・タイプ別セグメント：口腔分散性フィルム、口腔粘膜フィルム
- 世界の経口溶解フィルム製剤のタイプ別販売量（2018年-2023年）
- 世界の経口溶解フィルム製剤のタイプ別売上（2018年-2023年）
- 世界の経口溶解フィルム製剤のタイプ別価格

・用途別セグメント：病院、ドラッグストア、その他
- 世界の経口溶解フィルム製剤の用途別販売量（2018年-2023年）
- 世界の経口溶解フィルム製剤の用途別売上（2018年-2023年）
- 世界の経口溶解フィルム製剤の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
GSK、LTS、J&J、Indivior、Pfizer、Sanofi、Church & Dwight、tesa Labtec、Tapemark、Prestige、Sun Pharma、MonoSol、BioDelivery、Arx、ZIM、NAL Pharma、AdhexPharma、Aavishkar、IntelGenx Corp、APR

・産業チェーンと販売チャネルの分析
- 経口溶解フィルム製剤産業チェーン分析
- 経口溶解フィルム製剤の主要原材料
- 経口溶解フィルム製剤の販売チャネル
- 経口溶解フィルム製剤のディストリビューター
- 経口溶解フィルム製剤の主要顧客

・経口溶解フィルム製剤市場ダイナミクス
- 経口溶解フィルム製剤の業界動向
- 経口溶解フィルム製剤市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
Highlights
The global Orally Dissolving Film Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Orally Dissolving Film Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Orally Dissolving Film Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Orally Dissolving Film Drug include GSK, LTS, J&J, Indivior, Pfizer, Sanofi, Church & Dwight, tesa Labtec and Tapemark, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Orally Dissolving Film Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Dissolving Film Drug.
The Orally Dissolving Film Drug market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Orally Dissolving Film Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Dissolving Film Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
Segment by Type
Orodispersible Film
Oromucosal Film
Segment by Application
Hospitals
Drugstores
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Dissolving Film Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Dissolving Film Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Orally Dissolving Film Drug Market Overview
1.1 Product Overview and Scope of Orally Dissolving Film Drug
1.2 Orally Dissolving Film Drug Segment by Type
1.2.1 Global Orally Dissolving Film Drug Market Value Comparison by Type (2023-2029)
1.2.2 Orodispersible Film
1.2.3 Oromucosal Film
1.3 Orally Dissolving Film Drug Segment by Application
1.3.1 Global Orally Dissolving Film Drug Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Global Orally Dissolving Film Drug Market Size Estimates and Forecasts
1.4.1 Global Orally Dissolving Film Drug Revenue 2018-2029
1.4.2 Global Orally Dissolving Film Drug Sales 2018-2029
1.4.3 Global Orally Dissolving Film Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Orally Dissolving Film Drug Market Competition by Manufacturers
2.1 Global Orally Dissolving Film Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Orally Dissolving Film Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Orally Dissolving Film Drug Average Price by Manufacturers (2018-2023)
2.4 Global Orally Dissolving Film Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Orally Dissolving Film Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orally Dissolving Film Drug, Product Type & Application
2.7 Orally Dissolving Film Drug Market Competitive Situation and Trends
2.7.1 Orally Dissolving Film Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orally Dissolving Film Drug Players Market Share by Revenue
2.7.3 Global Orally Dissolving Film Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orally Dissolving Film Drug Retrospective Market Scenario by Region
3.1 Global Orally Dissolving Film Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Orally Dissolving Film Drug Global Orally Dissolving Film Drug Sales by Region: 2018-2029
3.2.1 Global Orally Dissolving Film Drug Sales by Region: 2018-2023
3.2.2 Global Orally Dissolving Film Drug Sales by Region: 2024-2029
3.3 Global Orally Dissolving Film Drug Global Orally Dissolving Film Drug Revenue by Region: 2018-2029
3.3.1 Global Orally Dissolving Film Drug Revenue by Region: 2018-2023
3.3.2 Global Orally Dissolving Film Drug Revenue by Region: 2024-2029
3.4 North America Orally Dissolving Film Drug Market Facts & Figures by Country
3.4.1 North America Orally Dissolving Film Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Orally Dissolving Film Drug Sales by Country (2018-2029)
3.4.3 North America Orally Dissolving Film Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orally Dissolving Film Drug Market Facts & Figures by Country
3.5.1 Europe Orally Dissolving Film Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Orally Dissolving Film Drug Sales by Country (2018-2029)
3.5.3 Europe Orally Dissolving Film Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Dissolving Film Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Orally Dissolving Film Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Orally Dissolving Film Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Orally Dissolving Film Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Orally Dissolving Film Drug Market Facts & Figures by Country
3.7.1 Latin America Orally Dissolving Film Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Orally Dissolving Film Drug Sales by Country (2018-2029)
3.7.3 Latin America Orally Dissolving Film Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orally Dissolving Film Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Dissolving Film Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Orally Dissolving Film Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Orally Dissolving Film Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Orally Dissolving Film Drug Sales by Type (2018-2029)
4.1.1 Global Orally Dissolving Film Drug Sales by Type (2018-2023)
4.1.2 Global Orally Dissolving Film Drug Sales by Type (2024-2029)
4.1.3 Global Orally Dissolving Film Drug Sales Market Share by Type (2018-2029)
4.2 Global Orally Dissolving Film Drug Revenue by Type (2018-2029)
4.2.1 Global Orally Dissolving Film Drug Revenue by Type (2018-2023)
4.2.2 Global Orally Dissolving Film Drug Revenue by Type (2024-2029)
4.2.3 Global Orally Dissolving Film Drug Revenue Market Share by Type (2018-2029)
4.3 Global Orally Dissolving Film Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Orally Dissolving Film Drug Sales by Application (2018-2029)
5.1.1 Global Orally Dissolving Film Drug Sales by Application (2018-2023)
5.1.2 Global Orally Dissolving Film Drug Sales by Application (2024-2029)
5.1.3 Global Orally Dissolving Film Drug Sales Market Share by Application (2018-2029)
5.2 Global Orally Dissolving Film Drug Revenue by Application (2018-2029)
5.2.1 Global Orally Dissolving Film Drug Revenue by Application (2018-2023)
5.2.2 Global Orally Dissolving Film Drug Revenue by Application (2024-2029)
5.2.3 Global Orally Dissolving Film Drug Revenue Market Share by Application (2018-2029)
5.3 Global Orally Dissolving Film Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Orally Dissolving Film Drug Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 LTS
6.2.1 LTS Corporation Information
6.2.2 LTS Description and Business Overview
6.2.3 LTS Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 LTS Orally Dissolving Film Drug Product Portfolio
6.2.5 LTS Recent Developments/Updates
6.3 J&J
6.3.1 J&J Corporation Information
6.3.2 J&J Description and Business Overview
6.3.3 J&J Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 J&J Orally Dissolving Film Drug Product Portfolio
6.3.5 J&J Recent Developments/Updates
6.4 Indivior
6.4.1 Indivior Corporation Information
6.4.2 Indivior Description and Business Overview
6.4.3 Indivior Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Indivior Orally Dissolving Film Drug Product Portfolio
6.4.5 Indivior Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pfizer Orally Dissolving Film Drug Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sanofi Orally Dissolving Film Drug Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Church & Dwight
6.6.1 Church & Dwight Corporation Information
6.6.2 Church & Dwight Description and Business Overview
6.6.3 Church & Dwight Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Church & Dwight Orally Dissolving Film Drug Product Portfolio
6.7.5 Church & Dwight Recent Developments/Updates
6.8 tesa Labtec
6.8.1 tesa Labtec Corporation Information
6.8.2 tesa Labtec Description and Business Overview
6.8.3 tesa Labtec Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 tesa Labtec Orally Dissolving Film Drug Product Portfolio
6.8.5 tesa Labtec Recent Developments/Updates
6.9 Tapemark
6.9.1 Tapemark Corporation Information
6.9.2 Tapemark Description and Business Overview
6.9.3 Tapemark Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Tapemark Orally Dissolving Film Drug Product Portfolio
6.9.5 Tapemark Recent Developments/Updates
6.10 Prestige
6.10.1 Prestige Corporation Information
6.10.2 Prestige Description and Business Overview
6.10.3 Prestige Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Prestige Orally Dissolving Film Drug Product Portfolio
6.10.5 Prestige Recent Developments/Updates
6.11 Sun Pharma
6.11.1 Sun Pharma Corporation Information
6.11.2 Sun Pharma Orally Dissolving Film Drug Description and Business Overview
6.11.3 Sun Pharma Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sun Pharma Orally Dissolving Film Drug Product Portfolio
6.11.5 Sun Pharma Recent Developments/Updates
6.12 MonoSol
6.12.1 MonoSol Corporation Information
6.12.2 MonoSol Orally Dissolving Film Drug Description and Business Overview
6.12.3 MonoSol Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 MonoSol Orally Dissolving Film Drug Product Portfolio
6.12.5 MonoSol Recent Developments/Updates
6.13 BioDelivery
6.13.1 BioDelivery Corporation Information
6.13.2 BioDelivery Orally Dissolving Film Drug Description and Business Overview
6.13.3 BioDelivery Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 BioDelivery Orally Dissolving Film Drug Product Portfolio
6.13.5 BioDelivery Recent Developments/Updates
6.14 Arx
6.14.1 Arx Corporation Information
6.14.2 Arx Orally Dissolving Film Drug Description and Business Overview
6.14.3 Arx Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Arx Orally Dissolving Film Drug Product Portfolio
6.14.5 Arx Recent Developments/Updates
6.15 ZIM
6.15.1 ZIM Corporation Information
6.15.2 ZIM Orally Dissolving Film Drug Description and Business Overview
6.15.3 ZIM Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.15.4 ZIM Orally Dissolving Film Drug Product Portfolio
6.15.5 ZIM Recent Developments/Updates
6.16 NAL Pharma
6.16.1 NAL Pharma Corporation Information
6.16.2 NAL Pharma Orally Dissolving Film Drug Description and Business Overview
6.16.3 NAL Pharma Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.16.4 NAL Pharma Orally Dissolving Film Drug Product Portfolio
6.16.5 NAL Pharma Recent Developments/Updates
6.17 AdhexPharma
6.17.1 AdhexPharma Corporation Information
6.17.2 AdhexPharma Orally Dissolving Film Drug Description and Business Overview
6.17.3 AdhexPharma Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.17.4 AdhexPharma Orally Dissolving Film Drug Product Portfolio
6.17.5 AdhexPharma Recent Developments/Updates
6.18 Aavishkar
6.18.1 Aavishkar Corporation Information
6.18.2 Aavishkar Orally Dissolving Film Drug Description and Business Overview
6.18.3 Aavishkar Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Aavishkar Orally Dissolving Film Drug Product Portfolio
6.18.5 Aavishkar Recent Developments/Updates
6.19 IntelGenx Corp
6.19.1 IntelGenx Corp Corporation Information
6.19.2 IntelGenx Corp Orally Dissolving Film Drug Description and Business Overview
6.19.3 IntelGenx Corp Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.19.4 IntelGenx Corp Orally Dissolving Film Drug Product Portfolio
6.19.5 IntelGenx Corp Recent Developments/Updates
6.20 APR
6.20.1 APR Corporation Information
6.20.2 APR Orally Dissolving Film Drug Description and Business Overview
6.20.3 APR Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2018-2023)
6.20.4 APR Orally Dissolving Film Drug Product Portfolio
6.20.5 APR Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Dissolving Film Drug Industry Chain Analysis
7.2 Orally Dissolving Film Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Dissolving Film Drug Production Mode & Process
7.4 Orally Dissolving Film Drug Sales and Marketing
7.4.1 Orally Dissolving Film Drug Sales Channels
7.4.2 Orally Dissolving Film Drug Distributors
7.5 Orally Dissolving Film Drug Customers
8 Orally Dissolving Film Drug Market Dynamics
8.1 Orally Dissolving Film Drug Industry Trends
8.2 Orally Dissolving Film Drug Market Drivers
8.3 Orally Dissolving Film Drug Market Challenges
8.4 Orally Dissolving Film Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 経口溶解フィルム製剤のグローバル市場2023年：口腔分散性フィルム、口腔粘膜フィルム(Global Orally Dissolving Film Drug Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

経口溶解フィルム製剤のグローバル市場2023年：口腔分散性フィルム、口腔粘膜フィルム

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp